Showing results (21-30 of 533) with videos related to
Sort By:
Pageof 54
ERJ Open Research|August 4, 2022
Differential responses of COPD macrophages to respiratory bacterial pathogensSimon Lea, Augusta Beech, James Baker, et al.Respiratory Research|December 10, 2020
The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPDJames Dean, Catalina Panainte, Naimat Khan, et al.ERJ Open Research|April 15, 2025
Two for the price of one: GLP-1 analogues, a new approach in treating severe COPD patients with diabetesAugusta Beech, Ernesto CrisafulliInternational Journal of Chronic Obstructive Pulmonary Disease|June 6, 2017
Clinical characteristics of COPD patients with tidal expiratory flow limitationJames Dean, Umme Kolsum, Paul Hitchen, et al.ERJ Open Research|November 11, 2021
Methacholine challenges: comparison of different tidal breathing challenge methodsJames Dean, Natalie Jackson, Brett Keidel-Morgan, et al.Plos One|February 10, 2021
Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarkerBert Rutten, Simon Young, Magdalena Rhedin, et al.Pulmonary Pharmacology & Therapeutics|December 18, 2019
FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methodsDave Singh, Naimat Khan, James Dean, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|July 8, 2026
COPD maintenance trials use heterogeneous outcomes and measurement instruments: a systematic literature reviewVi Truong, Sulaiman Bin Safar, Sachin Ananth, et al.Handbook of Experimental Pharmacology|November 14, 2016
Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial DesignDave SinghBritish Journal of Clinical Pharmacology|November 8, 2014
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectivesDave SinghPageof 54